Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 9Thoracic 3Gastrointestinal 3Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Neoplasm Metastasis 1

Interventions

Carboplatin 1170Cisplatin 890Pemetrexed 845pembrolizumab 624Paclitaxel 608Docetaxel 539Gemcitabine 428Radiotherapy 390Erlotinib Hydrochloride 381Nivolumab 344Bevacizumab 337Etoposide 296durvalumab 264Drug Therapy 260osimertinib 236atezolizumab 224Radiosurgery 194Gefitinib 186Vinorelbine 149Magnetic Resonance Spectroscopy 131Ipilimumab 129130-nm albumin-bound paclitaxel 125Cetuximab 113Blood Specimen Collection 106anlotinib 105tislelizumab 103Topotecan 103Specimen Handling 102Surgical Procedures, Operative 101Cyclophosphamide 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
linifanib × Thoracic × Clear all
NCT01225302 2017-11-21

A Study of Linifanib (ABT-869) in Combination With Carboplatin/Paclitaxel in Japanese Subjects With Non-Small Cell Lung Cancer (NSCLC)

AbbVie

Phase 1 Completed
12 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00716534 2013-04-29

Study of Carboplatin/Paclitaxel in Combination With ABT-869 in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

AbbVie

Phase 2 Completed
145 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00517790 2013-04-05

Study of ABT-869 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)

AbbVie

Phase 2 Completed
140 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡